Showing results (891-900 of 1,164) with videos related to
Sort By:
Pageof 117
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 3, 2007
The GlideScope-specific rigid stylet and standard malleable stylet are equally effective for GlideScope useTimothy P Turkstra, Christopher C Harle, Kevin P Armstrong, et al.Appetite|May 19, 2001
No unique role for nausea attributed to eating a food in the recalled acquisition of sensory aversion for that foodR C Knibb, D M Smith, D A Booth, et al.Proceedings of the National Academy of Sciences of the United States of America|January 10, 2012
Full-length myosin Va exhibits altered gating during processive movement on actinJessica M Armstrong, Elena Krementsova, Arthur J Michalek, et al.Cellular and Molecular Neurobiology|September 30, 2003
Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's diseaseDavid M Armstrong, Roxanne Sheffield, Amanda J Mishizen-Eberz, et al.Frontiers in Behavioral Neuroscience|January 10, 2019
Behavior Responses to Chemical and Optogenetic Stimuli in Drosophila LarvaeDavid A Clark, Seth R Odell, Joanna M Armstrong, et al.Cancer|September 1, 1976
Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow upA B Cruz, G Metter, D M Armstrong, et al.Journal of Wildlife Diseases|April 14, 2005
Serologic surveillance for selected viral agents in captive and free-ranging populations of Arabian oryx (Oryx leucoryx) from Saudi Arabia and the United Arab EmiratesKai Frölich, Christopher Hamblin, Sandra Jung, et al.Journal of Bacteriology|March 23, 2016
Rv2744c Is a PspA Ortholog That Regulates Lipid Droplet Homeostasis and Nonreplicating Persistence in Mycobacterium tuberculosisRichard M Armstrong, Katherine L Adams, Joseph E Zilisch, et al.Emerging Infectious Diseases|March 22, 2017
West Nile Virus Seroprevalence, Connecticut, USA, 2000-2014Megan E Cahill, Yi Yao, David Nock, et al.Journal of Diabetes and Its Complications|April 1, 1992
Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat TrialG Sundkvist, F M Armstrong, J E Bradbury, et al.Pageof 117